also reported ipilimumab use to increase AKI risk (HR 1.85, 95% CI 1.05 to 3.27), however, the calculated p-value (0.21) did not reach statistical significance [ 19 ].
← all excerpts
Immune checkpoint inhibitor-associated acute kidney injury and mortality: An observational study.
1
—
—